Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Flume

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 12, 2013
Deletion of airway cilia results in noninflammatory bronchiectasis and hyperreactive airwaysSandra K Gilley, Antine E Stenbit, Raymond C Pasek, et al.
The European Respiratory Journal|May 21, 2026
Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?James D Chalmers, Charles S Haworth, Patrick Flume, et al.
The European Respiratory Journal|June 10, 2017
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical researchAdam T Hill, Charles S Haworth, Stefano Aliberti, et al.
The European Respiratory Journal|September 28, 2025
European Respiratory Society clinical practice guideline for the management of adult bronchiectasisJames D Chalmers, Charles S Haworth, Patrick Flume, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The Lancet. Respiratory Medicine|August 26, 2014
Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trialsAlan F Barker, Anne E O'Donnell, Patrick Flume, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 12, 2013
Deletion of airway cilia results in noninflammatory bronchiectasis and hyperreactive airwaysSandra K Gilley, Antine E Stenbit, Raymond C Pasek, et al.
The European Respiratory Journal|May 21, 2026
Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?James D Chalmers, Charles S Haworth, Patrick Flume, et al.
The European Respiratory Journal|June 10, 2017
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical researchAdam T Hill, Charles S Haworth, Stefano Aliberti, et al.
The European Respiratory Journal|September 28, 2025
European Respiratory Society clinical practice guideline for the management of adult bronchiectasisJames D Chalmers, Charles S Haworth, Patrick Flume, et al.
Pageof 4